This inventor holds 1 USPTO granted patent. Top assignee: Samsung Life Public Welfare Foundation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Treatment: The Contributions of Inventor Seok-Hyung Kim
Introduction: Seok-Hyung Kim, an innovative inventor based in Seoul, South Korea, has made significant strides in the field of oncology through his focused research and dedicated work in antibody development. With a patent to his name, his contributions are noteworthy in advancing cancer treatment methodologies.
Latest Patents: Seok-Hyung Kim holds a patent for "Antibodies cross-reactive to human and mouse c-Met and uses thereof." This invention features an antibody that exhibits high specificity for human c-Met while also cross-reacting with mouse c-Met. This versatility allows for more accurate preclinical results, particularly in efficacy evaluations using mouse tumor models. The antibody effectively inhibits the growth of cancer cells from various types of cancer by binding with considerable affinity to c-Met, thereby suppressing its function and the associated signaling pathways. Additionally, the invention targets neovascularization, underscoring its potential in the prevention and treatment of cancers.
Career Highlights: Seok-Hyung Kim is currently associated with the Samsung Life Public Welfare Foundation, where his work focuses on developing innovative solutions in healthcare. His career has been marked by a commitment to addressing complex health challenges through targeted research and collaboration.
Collaborations: Throughout his career, Seok-Hyung Kim has collaborated with notable coworkers, including Do-Hyun Nam and Hyun-kyu Park. These collaborations reflect a synergy of expertise that enhances the quality and impact of their research in cancer treatment.
Conclusion: Seok-Hyung Kim's contributions to the field of oncology through his patented antibody technology represent a significant innovation in cancer treatment. His work, facilitated by collaboration within the Samsung Life Public Welfare Foundation, showcases the importance of continuous advancements in medical research aimed at improving patient outcomes in cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile